Intratio
Ricerca quantitativa
Vai al contenuto principale
Riepilogo di mercato IA
Caricamento informazioni di mercato...
  • Accedi
    Il mio account
    Esci

Lineage Cell Therapeutics, Inc. LCTX Previsione azionaria

Predizione di prezzo e analisi basata sull'AI per Lineage Cell Therapeutics, Inc. ยท Aggiornato Mag 13, 2026

Previsione AI a 90 giorni
MANTENERE
7 giorni
โ–ˆโ–ˆ%
30 giorni
โ–ˆโ–ˆ%
90 giorni
โ–ˆโ–ˆ%
Confidenza IA: 1% Correlazione di Spearman
Maggio 13, 2026

Scopri il target di prezzo esatto di LCTX

Crea un account gratuito per sbloccare le predizioni AI per oltre 4.000 titoli

Registrati gratis con Google
โœ“ Account gratuito ยท โœ“ Prova di 30 giorni ยท โœ“ Cancella quando vuoi

Prezzo e mercato

Caricamento grafico...

Statistiche chiave

Capitalizzazione di mercato
$332M
Rapporto P/B
6,15x
ROE
-56,7%
Margine netto
-4157,7%
Fatturato
$14M
Rapporto corrente
6,89x
Rapporto D/E
1,05x

Chi siamo Lineage Cell Therapeutics, Inc.

Lineage Cell Therapeutics, Inc. (LCTX) opera nel settore Life Sciences, specificamente nell'industria Biological Products, (No Diagnostic Substances). .

We do not have any company description for Lineage Cell Therapeutics, Inc. at the moment.

Life Sciences Biological Products, (No Diagnostic Substances) NYSE Small Cap

Ultime notizie

Biological Products, (No Diagnostic Substances) Aziende comparabili

Azienda Ticker Segnale AI Capitalizzazione di mercato P/E
Acumen Pharmaceuticals, Inc. ABOS โ–ˆโ–ˆ% $179M -x
Abpro Holdings, Inc. ABP โ–ˆโ–ˆ% $310K -x
Abpro Holdings, Inc. ABPO โ–ˆโ–ˆ% $1M -x
Arcellx, Inc. ACLX โ–ˆโ–ˆ% $6.73B -x
Alpha Cognition Inc. ACOG โ–ˆโ–ˆ% $119M -x
Adaptimmune Therapeutics Plc ADAP โ–ˆโ–ˆ% $77M -13,2x
Adma Biologics, Inc. ADMA โ–ˆโ–ˆ% $1.95B 11,8x
Adaptive Biotechnologies Corp ADPT โ–ˆโ–ˆ% $2.18B -x
Adverum Biotechnologies, Inc. ADVM โ–ˆโ–ˆ% $95M -1,8x
Agenus Inc AGEN โ–ˆโ–ˆ% $133M 2,1x
Agentix Corp. AGTX โ–ˆโ–ˆ% $2M -x
Aim Immunotech Inc. AIM โ–ˆโ–ˆ% $2M -x
Aim Immunotech Inc. AIMI โ–ˆโ–ˆ% $1M -x
Alector, Inc. ALEC โ–ˆโ–ˆ% $240M -x
Aligos Therapeutics, Inc. ALGS โ–ˆโ–ˆ% $40M -x
Allogene Therapeutics, Inc. ALLO โ–ˆโ–ˆ% $794M -x
Alvotech ALVO โ–ˆโ–ˆ% $1.11B -x
Amgen Inc AMGN โ–ˆโ–ˆ% $181.50B 23,3x
Apogee Therapeutics, Inc. APGE โ–ˆโ–ˆ% $6.21B -x
Aptose Biosciences Inc. APTOF โ–ˆโ–ˆ% $4M -x
Argenx Se ARGX โ–ˆโ–ˆ% $50.30B -x
Armata Pharmaceuticals, Inc. ARMP โ–ˆโ–ˆ% $330M -x
Artiva Biotherapeutics, Inc. ARTV โ–ˆโ–ˆ% $516M -x
Leonabio, Inc. ATHA โ–ˆโ–ˆ% $23M -0,2x
Atara Biotherapeutics, Inc. ATRA โ–ˆโ–ˆ% $84M -x
Atyr Pharma Inc ATYR โ–ˆโ–ˆ% $52M -x
Aura Biosciences, Inc. AURA โ–ˆโ–ˆ% $875M -x
Autolus Therapeutics Plc AUTL โ–ˆโ–ˆ% $426M -x
Anavex Life Sciences โ€ฆ AVXL โ–ˆโ–ˆ% $284M -x
Bioatla, Inc. BCAB โ–ˆโ–ˆ% $8M -x
Biocardia, Inc. BCDA โ–ˆโ–ˆ% $12M -x
Brainstorm Cell Therapeutics โ€ฆ BCLI โ–ˆโ–ˆ% $8M -x
Biocryst Pharmaceuticals Inc BCRX โ–ˆโ–ˆ% $2.24B -x
Black Diamond Therapeutics, โ€ฆ BDTX โ–ˆโ–ˆ% $162M -x
Beam Therapeutics Inc. BEAM โ–ˆโ–ˆ% $3.24B -x
Biogen Inc. BIIB โ–ˆโ–ˆ% $29.35B 21,4x
Biontech Se BNTX โ–ˆโ–ˆ% $23.69B -x
Cabaletta Bio, Inc. CABA โ–ˆโ–ˆ% $592M -x
Candel Therapeutics, Inc. CADL โ–ˆโ–ˆ% $639M -x
C4 Therapeutics, Inc. CCCC โ–ˆโ–ˆ% $330M -x
Cidara Therapeutics, Inc. CDTX โ–ˆโ–ˆ% $6.49B -1,0x
Creative Medical Technology โ€ฆ CELZ โ–ˆโ–ˆ% $8M -x
Cero Therapeutics Holdings, โ€ฆ CERO โ–ˆโ–ˆ% $1M -x
Cullinan Therapeutics, Inc. CGEM โ–ˆโ–ˆ% $992M -x
Compugen Ltd CGEN โ–ˆโ–ˆ% $268M 3,8x
Cg Oncology, Inc. CGON โ–ˆโ–ˆ% $6.34B -x
Cognition Therapeutics Inc CGTX โ–ˆโ–ˆ% $105M -x
Coherus Oncology, Inc. CHRS โ–ˆโ–ˆ% $264M 1,4x
Calidi Biotherapeutics, Inc. CLDI โ–ˆโ–ˆ% $3M -x
Cellectis S.A. CLLS โ–ˆโ–ˆ% $398M -x
Compass Therapeutics, Inc. CMPX โ–ˆโ–ˆ% $337M -x
Mosaic Immunoengineering Inc. CPMV โ–ˆโ–ˆ% $5M -x
Caribou Biosciences, Inc. CRBU โ–ˆโ–ˆ% $142M -1,5x
Cardiff Oncology, Inc. CRDF โ–ˆโ–ˆ% $112M -x
Cardiol Therapeutics Inc. CRDL โ–ˆโ–ˆ% $151M -x
Curis Inc CRIS โ–ˆโ–ˆ% $22M -x
Crispr Therapeutics Ag CRSP โ–ˆโ–ˆ% $5.09B -x
Champions Oncology, Inc. CSBR โ–ˆโ–ˆ% $87M -x
Cel Sci Corp CVM โ–ˆโ–ˆ% $10M -x
Dbv Technologies S.A. DBVT โ–ˆโ–ˆ% $1.18B -x
Dbv Technologies S.A. DBVTF โ–ˆโ–ˆ% $10K -x
Ginkgo Bioworks Holdings, โ€ฆ DNA โ–ˆโ–ˆ% $514M -x
Denali Therapeutics Inc. DNLI โ–ˆโ–ˆ% $3.09B -x
Precision Biosciences Inc DTIL โ–ˆโ–ˆ% $212M -x
Dyadic International Inc DYAI โ–ˆโ–ˆ% $26M -x
Editas Medicine, Inc. EDIT โ–ˆโ–ˆ% $287M -x
Eloxx Pharmaceuticals, Inc. ELOX โ–ˆโ–ˆ% $20K -x
Elutia Inc. ELUT โ–ˆโ–ˆ% $49M 0,9x
Engene Therapeutics Inc. ENGN โ–ˆโ–ˆ% $96M -x
Entera Bio Ltd. ENTX โ–ˆโ–ˆ% $68M -x
Viskase Holdings, Inc. ENZN โ–ˆโ–ˆ% $42M -x
Estrella Immunopharma, Inc. ESLA โ–ˆโ–ˆ% $52M -x
Evaxion A/S EVAX โ–ˆโ–ˆ% $35M -x
Exelixis, Inc. EXEL โ–ˆโ–ˆ% $12.55B 15,1x
Exozymes Inc. EXOZ โ–ˆโ–ˆ% $83M -x
Fate Therapeutics Inc FATE โ–ˆโ–ˆ% $260M -x
4d Molecular Therapeutics, โ€ฆ FDMT โ–ˆโ–ˆ% $540M -x
Fennec Pharmaceuticals Inc. FENC โ–ˆโ–ˆ% $240M -x
Finch Therapeutics Group, โ€ฆ FNCH โ–ˆโ–ˆ% $12M 0,5x
Finch Therapeutics Group, โ€ฆ FNCHQ โ–ˆโ–ˆ% $12M 0,5x
Futuretech Ii Acquisition โ€ฆ FTII โ–ˆโ–ˆ% $52M -x
Futuretech Ii Acquisition โ€ฆ FTIIU โ–ˆโ–ˆ% $14M -x
Gilead Sciences, Inc. GILD โ–ˆโ–ˆ% $167.60B 18,2x
Monte Rosa Therapeutics, โ€ฆ GLUE โ–ˆโ–ˆ% $1.61B -x
Genenta Science S.P.A. GNTA โ–ˆโ–ˆ% $14M -x
Green Planet Bio โ€ฆ GPLB โ–ˆโ–ˆ% $340K -x
Greenland Mines Ltd GRML โ–ˆโ–ˆ% $51M -x
Halozyme Therapeutics, Inc. HALO โ–ˆโ–ˆ% $8.41B 24,1x
Humacyte, Inc. HUMA โ–ˆโ–ˆ% $202M -x
Immunitybio, Inc. IBRX โ–ˆโ–ˆ% $8.50B -x
Inhibikase Therapeutics, Inc. IKT โ–ˆโ–ˆ% $254M -x
Imagenebio, Inc. IMA โ–ˆโ–ˆ% $65M -x
Immunocore Holdings Plc IMCR โ–ˆโ–ˆ% $1.49B -x
Immatics N.V. IMTX โ–ˆโ–ˆ% $1.53B -x
Immunovant, Inc. IMVT โ–ˆโ–ˆ% $5.83B -x
In8bio, Inc. INAB โ–ˆโ–ˆ% $16M -x
Inhibrx Biosciences, Inc. INBX โ–ˆโ–ˆ% $873M -6,8x
Mink Therapeutics, Inc. INKT โ–ˆโ–ˆ% $57M -x
Inmune Bio, Inc. INMB โ–ˆโ–ˆ% $37M -x
Intensity Therapeutics, Inc. INTS โ–ˆโ–ˆ% $12M -x
Iovance Biotherapeutics, Inc. IOVA โ–ˆโ–ˆ% $1.56B -x
Century Therapeutics, Inc. IPSC โ–ˆโ–ˆ% $413M -x
Invivyd, Inc. IVVD โ–ˆโ–ˆ% $420M -x
Jasper Therapeutics, Inc. JSPR โ–ˆโ–ˆ% $26M -x
Kalaris Therapeutics, Inc. KLRS โ–ˆโ–ˆ% $110M -x
Klotho Neurosciences, Inc. KLTO โ–ˆโ–ˆ% $56M -x
Kodiak Sciences Inc. KOD โ–ˆโ–ˆ% $2.45B -x
Krystal Biotech, Inc. KRYS โ–ˆโ–ˆ% $9.13B 40,6x
Kymera Therapeutics, Inc. KYMR โ–ˆโ–ˆ% $6.87B -x
Kyverna Therapeutics, Inc. KYTX โ–ˆโ–ˆ% $619M -x
Ladrx Corp LADX โ–ˆโ–ˆ% $20K -x
Lineage Cell Therapeutics, โ€ฆ LCTX โ–ˆโ–ˆ% $332M -x
Lenz Therapeutics, Inc. LENZ โ–ˆโ–ˆ% $248M -x
Atyr Pharma Inc LIFE โ–ˆโ–ˆ% $1.61B -x
Liminatus Pharma, Inc. LIMN โ–ˆโ–ˆ% $9M -x
Leonabio, Inc. LONA โ–ˆโ–ˆ% $96M -x
Lexeo Therapeutics, Inc. LXEO โ–ˆโ–ˆ% $422M -x
Maze Therapeutics, Inc. MAZE โ–ˆโ–ˆ% $1.28B -x
Mesoblast Ltd MESO โ–ˆโ–ˆ% $1.87B -x
Meiragtx Holdings Plc MGTX โ–ˆโ–ˆ% $906M -x
Metagenomi Therapeutics, Inc. MGX โ–ˆโ–ˆ% $51M -x
Molecular Partners Ag MOLN โ–ˆโ–ˆ% $163M -x
Moderna, Inc. MRNA โ–ˆโ–ˆ% $21.15B -x
Neurocrine Biosciences Inc NBIX โ–ˆโ–ˆ% $15.67B 23,4x
Nkgen Biotech, Inc. NKGN โ–ˆโ–ˆ% $2M -0,1x
Neumora Therapeutics, Inc. NMRA โ–ˆโ–ˆ% $342M -x
Novavax Inc NVAX โ–ˆโ–ˆ% $1.58B -x
Ocugen, Inc. OCGN โ–ˆโ–ˆ% $497M -x
Outlook Therapeutics, Inc. OTLK โ–ˆโ–ˆ% $29M -x
Palisade Bio, Inc. PALI โ–ˆโ–ˆ% $321M -x
Passage Bio, Inc. PASG โ–ˆโ–ˆ% $16M -x
Vaxcyte, Inc. PCVX โ–ˆโ–ˆ% $7.80B -x
Biomx Inc. PHGE โ–ˆโ–ˆ% $6M -x
Pluri Inc. PLUR โ–ˆโ–ˆ% $35M -x
Protalix Biotherapeutics, Inc. PLX โ–ˆโ–ˆ% $154M -x
Pharmacyte Biotech, Inc. PMCB โ–ˆโ–ˆ% $8M -x
Prime Medicine, Inc. PRME โ–ˆโ–ˆ% $596M -x
Prokidney Corp. PROK โ–ˆโ–ˆ% $537M -x
Pelthos Therapeutics Inc. PTHS โ–ˆโ–ˆ% $88M -x
Qiagen N.V. QGEN โ–ˆโ–ˆ% $7.31B -x
Quince Therapeutics, Inc. QNCX โ–ˆโ–ˆ% $21M 2,4x
Qrons Inc. QRON โ–ˆโ–ˆ% $150K -x
Replimune Group, Inc. REPL โ–ˆโ–ˆ% $326M -x
Repligen Corp RGEN โ–ˆโ–ˆ% $6.41B 124,7x
Regenxbio Inc. RGNX โ–ˆโ–ˆ% $521M -x
Relay Therapeutics, Inc. RLAY โ–ˆโ–ˆ% $2.45B -x
Revolution Medicines, Inc. RVMD โ–ˆโ–ˆ% $29.17B -x
Recursion Pharmaceuticals, Inc. RXRX โ–ˆโ–ˆ% $1.67B -x
Sab Biotherapeutics, Inc. SABS โ–ˆโ–ˆ% $254M -x
Sana Biotechnology, Inc. SANA โ–ˆโ–ˆ% $880M -x
Scilex Holding Co SCLX โ–ˆโ–ˆ% $48M -x
Scinai Immunotherapeutics Ltd. SCNI โ–ˆโ–ˆ% $2M -x
Sangamo Therapeutics, Inc SGMO โ–ˆโ–ˆ% $58M -x
Solid Biosciences Inc. SLDB โ–ˆโ–ˆ% $760M -x
Silexion Therapeutics Corp SLXN โ–ˆโ–ˆ% $2M -x
Senti Biosciences, Inc. SNTI โ–ˆโ–ˆ% $30M -x
Scholar Rock Holding โ€ฆ SRRK โ–ˆโ–ˆ% $5.86B -x
Surrozen, Inc./De SRZN โ–ˆโ–ˆ% $352M -x
Sutro Biopharma, Inc. STRO โ–ˆโ–ˆ% $678M -x
Protara Therapeutics, Inc. TARA โ–ˆโ–ˆ% $284M -x
Tarsus Pharmaceuticals, Inc. TARS โ–ˆโ–ˆ% $2.53B -x
Tc Biopharm (Holdings) โ€ฆ TCBPY โ–ˆโ–ˆ% $10K -x
Tscan Therapeutics, Inc. TCRX โ–ˆโ–ˆ% $74M -x
Bio-Techne Corp TECH โ–ˆโ–ˆ% $7.42B 67,7x
Tectonic Therapeutic, Inc. TECX โ–ˆโ–ˆ% $530M -x
Instil Bio, Inc. TIL โ–ˆโ–ˆ% $55M -x
Tenaya Therapeutics, Inc. TNYA โ–ˆโ–ˆ% $211M -x
Tourmaline Bio, Inc. TRML โ–ˆโ–ˆ% $1.23B -3,5x
Taysha Gene Therapies, โ€ฆ TSHA โ–ˆโ–ˆ% $1.93B -x
Titan Pharmaceuticals Inc TTNP โ–ˆโ–ˆ% $6M -0,5x
Tevogen Bio Holdings โ€ฆ TVGN โ–ˆโ–ˆ% $29M -x
Twist Bioscience Corp TWST โ–ˆโ–ˆ% $3.33B -x
Voyager Acquisition Corp./Cayman โ€ฆ VACH โ–ˆโ–ˆ% $387M 43,1x
Voyager Acquisition Corp./Cayman โ€ฆ VACHU โ–ˆโ–ˆ% $68M 6,7x
Valneva Se VALN โ–ˆโ–ˆ% $579M -x
Vericel Corp VCEL โ–ˆโ–ˆ% $1.69B 78,9x
Vir Biotechnology, Inc. VIR โ–ˆโ–ˆ% $1.49B -x
Vivosim Labs, Inc. VIVS โ–ˆโ–ˆ% $3M -x
Vor Biopharma Inc. VOR โ–ˆโ–ˆ% $856M -x
Vaxart, Inc. VXRT โ–ˆโ–ˆ% $164M 4,4x
Voyager Therapeutics, Inc. VYGR โ–ˆโ–ˆ% $251M -x
Windtree Therapeutics Inc โ€ฆ WINT โ–ˆโ–ˆ% $560K -x
X4 Pharmaceuticals, Inc XFOR โ–ˆโ–ˆ% $398M -x
Zeo Scientifix, Inc. ZEOX โ–ˆโ–ˆ% $18M -x
Zivo Bioscience, Inc. ZIVO โ–ˆโ–ˆ% $14M -x
Zura Bio Ltd ZURA โ–ˆโ–ˆ% $446M -x

FAQ

  • Lineage Cell Therapeutics, Inc. รจ un buon titolo da acquistare?

    La nostra AI analizza Lineage Cell Therapeutics, Inc. quotidianamente. Controlla il segnale sopra per l'ultima raccomandazione. Fai sempre le tue ricerche prima di investire.

  • Quanto sono accurate le previsioni di Lineage Cell Therapeutics, Inc.?

    La nostra AI raggiunge una correlazione di Spearman del 1% per questo titolo, con una precisione media superiore al 67% su oltre 4.000 titoli analizzati quotidianamente.

  • Con quale frequenza vengono aggiornate le previsioni?

    Le previsioni di Lineage Cell Therapeutics, Inc. vengono aggiornate quotidianamente utilizzando i dati di mercato piรน recenti e i modelli AI.

Pronto a investire in modo piรน intelligente?

Unisciti a migliaia di investitori che utilizzano previsioni azionarie basate sull'AI

Registrati gratis
โœ“ Account gratuito ยท โœ“ Oltre 4.000 titoli ยท โœ“ Aggiornamenti giornalieri

Cerchi un'analisi piรน approfondita di Lineage Cell Therapeutics, Inc.?

Visualizza l'analisi completa di livello istituzionale su Intratio โ†’

Le predizioni AI si basano su modelli storici e non dovrebbero essere l'unica base per le decisioni di investimento. Le performance passate non garantiscono risultati futuri. Fai sempre le tue ricerche.

I miei portafogli

Dashboard investimenti

Caricamento del tuo portafoglio...